U

Universidade Federal do Rio de Janeiro | Hospital Universitario Clementino Fraga filho

Research site

(Unclaimed)

Location

Street Professor Rodolpho Paulo Rocco, 255 - HUUCFF/ 9 andar/ Servico de Imunologia/ Sala 9E10 - Ilha do Fundao - Cidade Universitaria, Rio de Janeiro, Rio de Janeiro, Brazil

Site insights

Top conditions

Top treatments

Isavuconazole

BAL8557

Dexamethasone

Semaglutide

Teplizumab

Ambrisentan

LCI699

Fx-1006A

Parent organization

This site is a part of Universidade Federal do Rio de Janeiro

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes (βETA PRESERVE)

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment.The purpose of this study is to meas...

Enrolling

Type 1 Diabetes Mellitus

Other: Placebo

Drug: Teplizumab

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE)

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Active, not recruiting

Non-alcoholic Steatohepatitis

Drug: Placebo

Drug: Semaglutide